Hjem › Sigdcelleanemi › Alabama › Birmingham
Kliniske studier for Sigdcelleanemi i Birmingham, AL
14 studier for Sigdcelleanemi søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekruttererFase 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RekruttererFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Rekrutterer
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RekruttererFase 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekruttererObservasjonsstudie
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
RekruttererFase 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
RekruttererObservasjonsstudie
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RekruttererObservasjonsstudie
- University of Alabama, Birmingham (UAB), Birmingham
Sigdcelleanemi-studier i andre byer
- Atlanta, GA22 studier
- Washington, DC20 studier
- Memphis, TN18 studier
- Chicago, IL18 studier
- Philadelphia, PA15 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Durham, NC10 studier
- Cincinnati, OH10 studier
- Boston, MA10 studier
- Houston, TX10 studier
- Pittsburgh, PA9 studier
Andre studier i Birmingham
- Kreft (alle typer)30 studier
- Brystkreft24 studier
- Fedme23 studier
- Eggstokkreft23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Overvekt16 studier
- Endometriekreft16 studier
- Type 2-diabetes16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.